Search

Your search keyword '"Malecka-Panas E"' showing total 185 results

Search Constraints

Start Over You searched for: Author "Malecka-Panas E" Remove constraint Author: "Malecka-Panas E"
185 results on '"Malecka-Panas E"'

Search Results

1. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment

2. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment

3. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection

7. Recurrent acute pancreatitis prevention by the elimination of alcohol and cigarette smoking (REAPPEAR): protocol of a randomised controlled trial and a cohort study

9. Association of genetic variants affecting microRNAs and pancreatic cancer risk

10. Recurrent acute pancreatitis prevention by the elimination of alcohol and cigarette smoking (reappear): Protocol of a randmozied controlled trial and a cohort study

11. Common variants in glyoxalase I do not inease chronic pancreatitis risk

12. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

13. Analysis of GPRC6A variants in different pancreatitis etiologies

15. Randomised clinical trial: the efficacy and safety of propionyl-l-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment

17. Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma

18. Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

19. Common variants in glyoxalase I do not increase chronic pancreatitis risk

21. Corrigendum: Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms [Carcinogenesis, 39, 3, (2018), (360-367)] DOI: 10.1093/carcin/bgx150

22. SLC22A3 polymorphisms may influence overall patient survival-PANDORA study

23. Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms

24. Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation

26. EU Pancreas: An Integrated European Platform for Pancreas Cancer Research - from Basic Science to Clinical and Public Health Interventions for a Rare Disease

27. Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis

28. Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis

29. Association of variants of genes involved in mitochondrial metabolism with pancreatic cancer risk

30. Identification of recessively inherited genetic variants for pancreatic cancer risk

31. Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation

32. SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival

34. ROLE OF ADIPOKINES IN THE ASSESSMENT OF SEVERITY AND PREDICTING THE CLINICAL COURSE OF ACUTE PANCREATITIS.

35. CLINICAL SIGNIFICANCE OF ACTIVIN A AND MYOSTATIN IN PATIENTS WITH PANCREATIC ADENOCARCINOMA AND PROGRESSIVE WEIGHT LOSS.

36. Polymorphic variants within non-coding RNA and risk of pancreatic ductal adenocarcinoma

37. Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors

38. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21

39. Functional single nucleotide polymorphisms within the cyclindependent kinase inhibitor 2A/2B region affect pancreatic cancer risk

40. Polymorphism of taste receptor genes (TASRs) and risk of pancreatic cancer

41. Ustekinumab as induction and maintenance therapy for Crohn's disease

42. Umfangreiche epidemiologische und Genotyp-Phänotyp (GxP) Analysen in dem weltweit größten Patientenkollektiv mit idiopathischer Achalasie

45. Polymorphisms at PRSS1-PRSS2 and CLDN2-MORC4 loci associate with alcoholic and non-alcoholic chronic pancreatitis in a European replication study

46. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer

47. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21

48. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection

Catalog

Books, media, physical & digital resources